ICD-10 Coding for Endocrine Tumor(E34.0U)
Comprehensive guide to ICD-10 coding for endocrine tumors, including benign and malignant neuroendocrine tumors. Learn about code ranges, documentation requirements, and common pitfalls.
Complete code families applicable to Endocrine Tumor
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D3A.0 | Benign carcinoid tumors of the gastrointestinal tract | Use for confirmed benign carcinoid tumors in the GI tract. |
|
| C7A.0 | Malignant carcinoid tumors of the gastrointestinal tract | Use for confirmed malignant carcinoid tumors in the GI tract. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEndocrine Tumor
Documentation & Coding Risks
Avoid these common issues when documenting Endocrine Tumor.
Omitting metastatic sites in documentation
Impact
Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential for denied claims
Mitigation
Ensure all metastatic sites are documented in the medical record.
Using the Neoplasm Table for carcinoid tumors
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues, Compliance: Potential for coding audits and compliance issues, Data Quality: Inaccurate clinical data affecting patient care
Mitigation
Refer to the alphabetic index for accurate coding.
Incorrect tumor classification
Impact
Risk of classifying malignant tumors as benign due to incomplete documentation.
Mitigation
Implement thorough documentation review processes.